Company
Altamira Therapeutics Ltd. (CYTOF)
Standardized SEC financial data for Altamira Therapeutics Ltd. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001601936 · OTC · Pharmaceutical Preparations.
Revenue growth (YoY)
378.4%
Return on equity
-127.0%
Ratios for fiscal year 2022, standardized from SEC filings.
Income statement
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | $64K | $306K | — |
| Cost of revenue | — | — | — | $2.2M | $1.4M | $34K |
| Gross profit | — | — | — |
Standardized from Altamira Therapeutics Ltd.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|
| Total assets | $9.9M | $9.2M | $20.8M | $19.2M | $6.3M | $7.7M |
| Total liabilities |
Get CYTOF data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CYTOF/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CYTOF/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"